Background
• 'paediatric musculoskeletal matters' (PMM-www.pmmonline.org, (Figure 1) is a free, evidence-based and peer reviewed open e-resource for paediatric musculoskeletal (MSK) medicine targeting non-MSK specialists [1] [2] [3] . Since launch (Nov-2014) PMM has reached 200 countries with >116,700 users, >335,000 hits (data taken June-2018). PMM has been endorsed by PReS as a educational resource for members to aid their teaching to medical students and non-specialists (https://www.pres.eu/activities/scientific-and-clinical/ educational-instruments-and-tools.html).
• Registration to PMM is needed to access clinical videos (e.g. pGALS [4, 5] demonstrations). Registered users are mainly non-MSK specialists (medical students, primary care and paediatric trainees).
• Feedback from users has requested further content to reflect international healthcare systems. PMM India was developed in collaboration with the Indian Academy of Paediatrics (IAP; Sept-2015, >4,400 users, 17,800 hits to date) and showcases successful partnership with local clinicians in developing PMM with local context. • Further 'internationalisation' with additional global partners to develop 'PMM International' to replace the existing PMM site is almost complete. Here, we describe the process for international development.
Methods
• Paediatric rheumatologists around the world were approached to identify additional PMM content to reflect MSK medicine in their healthcare systems (e.g. variation in case mix, clinical presentations, care pathways), with the focus being the level of knowledge relevant for non-MSK specialists.
• New content was developed by local teams identified by the paediatric rheumatologist(s) who then collated and provided expert overview. This new content was submitted for editorial review and peer review.
• The feedback was for the main language for PMM to remain in English with request for pGALS translations.
• Additional cases and images were submitted with appropriate consent.
• The new platform will be free and open to all, and be accessible on the new PReS education website.
Conclusions
• Additions to the original PMM website predominately focus on infections / infection-related disease with MSK features or as differential diagnoses for rheumatic disease.
• There were requests for translation of pGALS. The list of languages to be available (so far) is the following;
• A PMM app is planned to facilitate access where internet capacity is limited. Content and format will be determined in consultation with users.
• Rapid globalisation necessitates appropriate e-resources with content that reflect international healthcare contexts.
• PMM targets non-MSK specialist audiences to raise awareness and early recognition of MSK pathology.
• Our work reflects strong collaborative global partnerships within the paediatric rheumatology community.
• PMM has been endorsed by NICE, RCN and BSPAR; PReS recommends PMM as a resource to be used by specialists to aid their teaching to medical students and non-specialists.
• PMM is available to all as a free resource (and available through the new PReS education website). PMM International will be launched in the upcoming months.
• Implementation of PMM has yet to be formally evaluated, but data so far, supports wide reach and positive uptake with most users being non-specialists.
• PMM-Nursing is also now live and targets the learning needs of students and all nurses involved in the care of children and young peoplewww.pmmonline.org/nurse. 
